vialroom

#semaglutide 2025-08-31

Sunday49 messages12 participantstimes are UTC
Highlights from this day
  • amsterdam_aliquot — my plateau was the scale stopping while appetite stayed suppressed, which is a different problem 17:01
  • igf_one_ivy — anyone gone from 5 straight to 7.5 or is that too big a jump 17:56
  • a1c_lag — restarted after 21 months off at a low dose and the nausea arrived exactly like the first time 18:26
VB

Assay note: SSA lot H-2814 reported at 99.2% of label content.

A1

if youre comparing brand to compounded, dose accuracy in the vial is the variable, not the molecule
the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing

2.4 is the ceiling

VO

five week steps worked better for me than four, purely on how the second week felt

back after 16 months off, do i restart at 0.25 or somewhere higher

A1

STEP 4 had the withdrawal arm, thats the one people quote when they talk about stopping

give it four weeks

MM

anyone compared their 4 vial dosing against the pen increments

PS

quick one went to 2.4 and the extra suppression wasnt worth the GI for me, so i came back down

mine faded too

🙏10

lost about 17kg on the low doses before i even got to 1, which surprised me

half life is about a week so youre roughly four to five weeks to steady state on any new dose

PS

vial units and pen clicks are different systems, mixing the two is how people end up wrong

4❤️2

does anyone actually run a five week step instead of four

A1

the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing

AA

went 1 to 1.7 too fast and spent two weeks regretting it, dropped back and repeated the step

my plateau was the scale stopping while appetite stayed suppressed, which is a different problem

8🔥11🧊1

seven days ish

thats STEP 1

DV

steady state is the bit people skip, judging a new dose after eight days tells you almost nothing

is there a reason to hold at 1.7 rather than going to 2.4

⚠️18

*Janoshik not the other one

FLOW was the kidney outcomes trial and it gets quoted in here for things it didnt measure

wk 1-4    0.25mg
wk 5-10   0.50mg   (held 2 extra weeks)
wk 11-14  1.00mg
wk 15-26  1.70mg   (held, long)
wk 27+    2.40mg
DE

i held at 10 for 6 months and it was the best decision i made

IO

SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

IO

anyone gone from 5 straight to 7.5 or is that too big a jump

wk 1-4    0.25mg
wk 5-10   0.50mg   (held 2 extra weeks)
wk 11-14  1.00mg
wk 15-26  1.70mg   (held, long)
wk 27+    2.40mg
⚠️5📉5👀1
IO

the long half life flattens the trough more than people expect, i never felt a day seven dip

A1

what did SELECT actually measure, i see it quoted for everything

A1

restarted after 21 months off at a low dose and the nausea arrived exactly like the first time

💀18🙏12

plateaus move

👀12🎉11📉1
DE

moving my dose day by a day or two never did anything noticeable for me

VB

Inter-lab diff for lot A-2601: 98.1% vs 99%. Within expected range.

AA

i dont think the plateau is a dose problem most of the time, but i cant prove that

👀14⚠️18
SO

the appetite effect faded for me around 24 months and going up fixed it for a while

DE

compounded and brand felt the same to me at 12, which is one person and nothing more

26 months at 2.4 and the honest summary is diminishing returns after the first half

ST

did anyone titrate slower than four weeks a step and how did that go